Use of Traumatic Brain Injury Biomarkers after a Potentially Concussive Event
BACKGROUND
STRUCTURE TO SUPPORT OPTIMAL USE OF TBI BIOMARKER
INITIAL EVALUATION
RISK EVALUATION FOR BRAIN INJURY & INTRACRANIAL HEMORRHAGE
HIGH RISK: DO NOT DELAY CARE FOR TBI WHOLE BLOOD BIOMARKER
MODERATE RISK: TEST TBI WB BIOMARKERS BEFORE EVACUATION
LOW RISK FOR TBI: NO RISK FACTORS PRESENT
LOCATIONS WITH ON-SITE HEAD CT
PRIMARY CONCUSSIVE BLAST
SYMPTOMATIC TREATMENT OF MILD TBI
PERFORMANCE IMPROVEMENT (PI) MONITORING
REFERENCES
APPENDIX A: CLINICAL ALGORITHM FOR TBI BLOOD BIOMARKERS USE
APPENDIX B: DETAILED INFORMATION ON THE TBI WB BIOMARKER
APPENDIX C: SUMMARY OF RESEARCH
APPENDIX D: CLASS VIII PLACEHOLDER
APPENDIX E: TELEMEDICINE/TELECONSULTATION
APPENDIX F: INFORMATION REGARDING OFF-LABEL USES IN CPGS
DOWNLOAD CPG IN PDF